Skip to content

Charles River Laboratories CRL Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax

Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax at other companies

Allegion logo
AllegionALLE
$525K+291%
Lamar Advertising logo
Lamar AdvertisingLAMR
-$543K-480%
AECOM logo
AECOMACM
$22.8M+47.1%
Aptiv logo
AptivAPTV
-$283M-261%
FCF
FirstCash HoldingsFCFS
$0
General Mills logo
General MillsGIS

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax?
Charles River Laboratories (CRL) reported other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax of -$25.18M in Q1 2026.
How has Charles River Laboratories's other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax changed year-over-year?
Charles River Laboratories's other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax decreased by 141.7% year-over-year, from $60.38M to -$25.18M.
What is the long-term trend for Charles River Laboratories's other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax?
Over 2 years (2023 to 2025), Charles River Laboratories's other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax has grown at a 55.8% compound annual growth rate (CAGR), from $70.65M to $171.5M.
What does other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax mean?
Gains or losses caused by changes in foreign exchange rates on international assets.
How do you interpret other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax?
Positive values indicate a strengthening of foreign currencies against the reporting currency, while negative values indicate a weakening.
How does other comprehensive income foreign currency transaction and translation gain loss before reclassification and tax compare across companies?
Common for multinational corporations with significant international operations.